Novato / Washington / D.C. / Phoenix / Digital Dr Novato / Drive Novato / Dr Novato / /
Company
BioMarin Pharmaceutical Inc. / Thomas R. Pollock Paul Hastings LLP / Asset Management LLC / Johnson & Johnson / PepsiCo Inc. / Charles Schwab & Company / BioMarln Phermaceutlcal Inc. / Dale Wannen Sustainvest Asset Management LLC / Thomas Industries Inc. / Datastream Systems Inc. / Bob Evans Farms Inc. / Pfizer / I IJ Corporate Secretary BioMarin Pharmaceutical Inc. / Orate Secretary BloMerln Pharmaceutical Inc. / Smithfield Foods Inc. / American Express Company / Tootsie Roll Industries Inc. / BioMarin Phannaceutical Inc. / Bloomberg / Abbott Laboratories / BioMarin Pharmaceuticals / Paul Hastings LLP / /
Currency
pence / USD / / /
Event
M&A / General or Shareholder Meeting / /
Facility
A Institute / Accountability Institute / /
IndustryTerm
pharmaceutical / /
MarketIndex
S&P 500 and 57 / /
Organization
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON / D.C. / United States Securities and Exchange Commission / U.S. District Court / U.S. Securities and Exchange Commission / office of Chief Counsel Division / Client Service / DIVISION OF CORPORATION FINANCE / /
Person
Dale Wannen / Pollock / Laura Woodhead / Evan S. Jacobson / Eric Davis / Matt S. McNair / PAUL HASTINGS / / /
Position
Counsel / Corporate Secretary / General Counsel / on behalf / President / Special Counsel DIVISION OF CORPORATiO~ FINANCE / Deputy General Counsel / Specialist / General / Vice President and General Counsel / Secretary / Governor / executive / representative / Special Counsel / /
BioMarin Pharmaceutical Inc.; Rule 14a-8 no-action letter